Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, M., Israel, H., Rybczyk, K. et al. (2001). Trial-related discrimination in HIV vaccine clinical trials. AIDS Research and Human Retroviruses, 17, 667–674.
American Medical Association, Council on Ethical and Judicial Affairs. (2000). Fee splitting: Referrals to health care facilities (Opinion E-603). In American Medical Association Council on Ethical and Judicial Affairs, Code of Medical Ethics: Current Opinions. Chicago, Illinois: Author.
American Medical Association, Council on Ethical and Judicial Affairs. (1994). Finder’s Fees: Payment for the Referral of Patients to Clinical Research Studies (report #65). Chicago, Illinois: Author.
Ananworanich, J., Cheunyam, T., Teeratakulpisarn, S., et al. (2004). Creation of a drug fund for post-clinical trial access to antiretrovirals. Lancet, 364, 101–102.
Angell, M. (1997). The ethics of clinical research in the Third World. New England Journal of Medicine, 337, 847–849.
Annas, G.J. & Grodin, M.A. (1998). Human rights and maternal-fetal HIV transmission prevention trials in Africa. American Journal of Public Health, 88(4), 560–563.
Armistead, L.P., Clark, H., Barber, C.N., Dorsey, S., Hughley, J., Favors, M., & Wyckoff, S.C. (2004). Participant retention in the Parents Matter! Program: Strategies and out-come. Journal of Child and Family Studies, 13(1), 67–80.
Bayer, R. (1998). The debate over maternal-fetal HIV transmission prevention trials in Africa, Asia, and the Caribbean: Racist exploitation or exploitation of racism? American Journal of Public Health, 88(4), 567–570.
Bloom, B.R. (1998). The highest attainable standard: Ethical issues in AIDS vaccines. Science, 279 (5348), 186–188.
Bodenheimer, T. (2000). Uneasy alliance: Clinical investigators and the pharmaceutical industry. New England Journal of Medicine, 342, 1539–1543.
Canadian HIV/AIDS Legal Network. (2002). HIV Vaccines in Canada: Legal and Ethical Issues. An Overview. Toronto, Canada: Author.
Caschetta, M.B., Chavkin, W., & McGovern, T. (1993). FDA policy on women in drug trials [correspondence]. New England Journal of Medicine, 329, 1815.
Chow, S.C. & Liu, J-P. (2003). Design and Analysis of Clinical Trials: Concepts and Methodologies. Hoboken, New Jersey: John Wiley & Sons, Inc.
Collins, A. & Baumgartner, D. (1995). U.S. prisoners’ access to experimental HIV thera-pies. Minnesota Medicine, 78(11), 45–48.
Connor, E.M., Sperling, R.S., Gelber, R., et al. (1994). Reduction of maternal-infant trans-mission of HIV type I with ZDV treatment. New England Journal of Medicine, 331, 1173–1180.
Council of International Organizations for Medical Sciences. (2002). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, Switzerland: Author.
Crouch, R.A. & Arras, J.D. (1998). AZT trials and tribulations. Hastings Center Report, 28(6), 26–34.
Daunt, D.J. (2003). Ethnicity and recruitment rates in clinical research studies. Applied Nursing Research, 16(3), 189–195.
De Zoysa, I., Elias, C.J., & Bentley, M.E. (1998). Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention. American Journal of Public Health, 88(4), 571–575.
De Zulueta, P. (2001). Randomised placebo-controlled trials in HIV-infected pregnant women in developing countries. Ethical imperialism or unethical exploitation? Bioethics, 15(4), 289–311.
DeAngelis, C.D. (2001). Conflict of interest and the public trust [editorial]. Journal of the American Medical Association, 284, 2237–2238.
DeVesa, F. (1993). Opinion letter from Attorney General of New Jersey to Commissioner W.H. Fauver, New Jersey Department of Corrections, November 30. Cited in G.L. Stein & L.D. Headley. (1996). Forum on prisoners’ access to clinical trials: Summary of recommendations. AIDS & Public Policy Journal, 11(1), 3–20.
Edi-Osagie, E.C.O. & Edi-Osagie, N.E. (1998). Placebo trials are unethical for estab-lished, untested treatments. British Medical Journal, 316, 625.
Faden, R. & Kass, N. (1998). HIV research, ethics, and the developing world [editorial]. American Journal of Public Health, 88(4), 548–550.
Family Health Research Group. (1998). The Family Health Project: A multidisciplinary longitudinal investigation of children whose mothers are HIV-infected. Clinical Psychology Review, 18, 839–856.
Feinberg, J. & Japour, A.J. (2003). Scientific and ethical considerations in trial design for investigational agents for the treatment of human immunodeficiency virus. Clinical Infectious Diseases, 36, 201–206.
Food and Drug Administration. (1998). Information Sheets: Guidance for Institutional Review Boards and Clinical Investigators. Rockville, Maryland: Author.
Freedman, B. (1991). Suspended judgment: AIDS and the ethics of clinical trials: Learning the right lessons. Controlled Clinical Trials, 13(1), 1–5.
Frey, S.E. (2003). Unique risks to volunteers in HIV vaccine trials. Journal of Investigative Medicine, 51 (Supp. 1), S18-S20.
Grosskurth, H., Mosha, F., Todd, J. et al. (1995). Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: Randomized controlled trial. Lancet, 346, 530–536.
Habiba, M. & Evans, M. (2002). The inter-role confidentiality conflict in recruitment for clinical research. The Journal of Medicine and Philosophy, 27(5), 565–587.
Halsey, N.A., Sommer, A., & Black, R.E. (1998). Authors’ reply. British Medical Journal, 316, 627.
Heckerling, P.S. (2005). The ethics of single-blind trials. IRB: Ethics & Human Research, 27(4), 12–16.
Henderson, J.A. & Smith, J.J. (2002). Financial conflict of interest in medical research: Overview and analysis of federal and state controls. Food and Drug Law Journal, March, 1–11.
Homer, C.S.E. (2002). Using the Zelen design in randomized controlled trials: Debates and controversies. Journal of Advanced Nursing, 38(2), 200–207.
Iltis, A.S. (2005). Timing invitations to participate in clinical research: Preliminary versus informed consent. Journal of Medicine and Philosophy, 30, 89–106.
Institute of Medical Ethics Working Party on the Ethical Implications of AIDS. (1992). British Medical Journal, 305, 699–701.
Kaiser, J. (1997). Bangkok study adds fuel to AIDS ethics debate. Science, 278 (5343), 1553.
Kass, N.E., Taylor, H.A., & King, P.A. (1996). Harms of excluding pregnant women from clinical research: The case of HIV-infected pregnant women. Journal of Law, Medicine & Ethics, 24, 36–46.
Kent, D.M., Mwamburi, M., Cash, R.A., Tabin, T.L., & Bennish, M.L. (2003). Testing therapies less effective than the best current standard: Ethical beliefs in an international sample of researchers. American Journal of Bioethics, 3(2), W28-W33.
Killen, J., Grady, C., Folkers, G.K., & Fauci, A.S. (2002). Ethics of clinical research in the developing world. Nature Reviews, 2, 210–215.
Kodish, E., Lantos, J.D., & Siegler, M. (1990). Ethical considerations in randomized controlled clinical trials. Cancer, 65 (Suppl.), 2400–2404.
Korn, D. (2000). Conflicts of interest in biomedical research. Journal of the American Medical Association, 284, 2234–2237.
Last, J.M. (Ed.) (1988). A Dictionary of Epidemiology, 2nd ed. New York: Oxford University Press.
Lemmens, T. & Miller, P.B. (2003). The human subjects trade: Ethical and legal issues surrounding recruitment incentives. Journal of Law, Medicine & Ethics, 31, 398–418.
Levine, R.J. (1985). The use of placebos in randomized controlled clinical trials. IRB: A Review of Human Subjects Research, 7, 1–6.
Lo, B., Wolf, L.E., & Berkeley, A. (2000). Conflict-of-interest policies for investigators in clinical trials. New England Journal of Medicine, 343, 1616–1620.
Loue, S., Lurie, P., & Lloyd, L.S. (1995). Ethical issues raised by needle exchange programs. Journal of Law, Medicine, and Ethics, 23(4), 382–388.
Loue, S., Okello, D., & Kawuma, M. (1996). Research bioethics in the Ugandan context. Journal of Law, Medicine, and Ethics, 24(1), 47–53.
Lurie, P., Bishaw, M., Chesney, M.A. et al. (1994). Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. Journal of the American Medical Association, 271(4), 295–301.
Lurie, P. & Wolfe, S.M. (1997). Unethical trials of interventions to reduce perinatal transmis-sion of human immunodeficiency virus in developing countries. New England Journal of Medicine, 337, 853–856.
Macklin, R. & Friedland, G. (1986). AIDS research: The ethics of clinical trials. Law, Medicine & Health Care, 14(5–6), 273–280.
Meinert, C.L. (1986). Clinical Trials: Design, Conduct, and Analysis. New York: Oxford University Press.
Moodley, K. (2002). HIV vaccine trial participation in South Africa—An ethical assessment. Journal of Medicine and Philosophy, 27(2), 197–215.
Moore v. Regents of the University of California. (1990). 793 P.2d 479, cert. denied, 499 U.S. 936 (1991).
Mugerwa, R.D., Kaleebu, P., Mugyenyi, P. et al. (2002). First trial of the HIV-1 vaccine in Africa: Ugandan experience. British Medical Journal, 324, 226–229.
Muthuswamy, V. (2005). Ethical issues in HIV/AIDS research. Indian Journal of Medical Research, 121, 601–610.
Nairn, T.A. (1993). The use of Zairian children in HIV vaccine experimentation: A cross-cultural study in medical ethics. The Annual of the Society of Christian Ethics, 13, 223–243.
National Commission for the Protection of Human Subjects. (1979). The Belmont Report. Washington, D.C.: United States Department of Health and Human Services.
National Institutes of Health. (2005). An Introduction to Clinical trials. Available at http://www.clinicaltrials.gov. Last accessed August 14, 2006.
Pasquerella, L. (2002). Confining choices: Should inmates’ participation in research be limited? Theoretical Medicine, 23, 519–536.
Porter, J.D.H., Forrest, B.D., & Kennedy, A.R. (1992). The ethics of placebos in AIDS drug trials. Healthcare Ethics Committee Forum, 4(3), 155–162.
Resnik, D.B. (2003). Exploitation in biomedical research. Theoretical Medicine, 24, 233–259.
Roe v. Fauver. (1992). Consent decree. C.A. No. 88–1225-AET (D. New Jersey, March 3).
Schüklenk, U. (1998). Unethical perinatal HIV transmission trials establish bad precedent. Bioethics, 12, 312–319.
Sheon, A.R., Wagner, L., McElrath, M.J. et al. (1998). Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons learned from a phase II trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19, 519–526,
Simberkoff, M.S., Hamilton, J.D., Gail, M. et al. (1993). Ethical dilemmas in continuing a zidovudine trial after early termination of similar trials. Controlled Clinical Trials, 14(1), 6–18.
Stein, G.L. & Headley, L.D. (1996). Forum on prisoners’ access to clinical trials: Summary of recommendations. AIDS & Public Policy Journal, 11(1), 3–20.
Stein, R.E. (1994). Vaccine liability and participant compensation incentives in HIV vaccine trials. AIDS Research and Human Retroviruses, 10(Supp. 2), S297-S300.
Stone, V.E., Steger, K.A., Hirschorn, L.R. et al. (1998). Access to treatment with protease inhibitor containing regimens: Is it equal for all? Presented at the 12th International AIDS Conference, Geneva, Switzerland, June 28-July 3 [abstract no. 42305].
Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law No. 10, Vol. 2 (pp. 181–182). Nuremberg October 1946 – April 1949, Washington. U.S. Government Printing Office (n.d.).
UNAIDS. (2000). Ethical Considerations in HIV Preventive Vaccine Research: UNAIDS Guidance Document. Geneva, Switzerland: Joint United Nations Programme on AIDS. Available at http://www.unaids.org.
Varmus, H. & Satcher, D. (1997). Ethical complexities of conducting research in develop-ing countries. New England Journal of Medicine, 337(14), 1003–1005.
Veatch, R.M. (1989). Drug research in humans: The ethics of nonrandomized access. Clinical Pharmacy, 8(5), 366–370.
Wadman, M. (1996). Drug company “suppressed” publication of research. Nature, 381(6577), 4.
World Medical Association. (1964). Declaration of Helsinki.
World Medical Association. (1996, 2002). Declaration of Helsinki.
Writing Committee. (1999). Science, ethics, and the future of research into maternal infant transmission of HIV-1. Lancet, 353, 832–835.
Zelen, M. (1979). A new design for randomized controlled trials. New England Journal of Medicine, 300, 1242–1245.
Zelen, M. (1990). Strategy and alternative designs for clinical trials: An update. Statistics in Medicine, 9, 645–656.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Loue, S., Pike, E.C. (2007). Clinical Trials. In: Case Studies in Ethics and HIV Research. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-71362-5_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-71362-5_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-71361-8
Online ISBN: 978-0-387-71362-5
eBook Packages: MedicineMedicine (R0)